TY - JOUR
T1 - Differential toxicity profile of secreted and processed α-Klotho expression over mineral metabolism and bone microstructure
AU - Roig-Soriano, Joan
AU - Sánchez-de-Diego, Cristina
AU - Esandi-Jauregui, Jon
AU - Verdés, Sergi
AU - Abraham, Carmela R
AU - Bosch i Merino, Assumpció
AU - Ventura, Francesc
AU - Chillón Rodríguez, Miguel
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/3/14
Y1 - 2023/3/14
N2 - The aging-protective gene α-Klotho (KL) produces two main transcripts. The full-length mRNA generates a transmembrane protein that after proteolytic ectodomain shedding can be detected in serum as processed Klotho (p-KL), and a shorter transcript which codes for a putatively secreted protein (s-KL). Both isoforms exhibit potent pleiotropic beneficial properties, although previous reports showed negative side effects on mineral homeostasis after increasing p-KL concentration exogenously. Here, we expressed independently both isoforms using gene transfer vectors, to assess s-KL effects on mineral metabolism. While mice treated with p-KL presented altered expression of several kidney ion channels, as well as altered levels of P and Ca 2+ in blood, s-KL treated mice had levels comparable to Null-treated control mice. Besides, bone gene expression of Fgf23 showed a fourfold increase after p-KL treatment, effects not observed with the s-KL isoform. Similarly, bone microstructure parameters of p-KL-treated mice were significantly worse than in control animals, while this was not observed for s-KL, which showed an unexpected increase in trabecular thickness and cortical mineral density. As a conclusion, s-KL (but not p-KL) is a safe therapeutic strategy to exploit KL anti-aging protective effects, presenting no apparent negative effects over mineral metabolism and bone microstructure.
AB - The aging-protective gene α-Klotho (KL) produces two main transcripts. The full-length mRNA generates a transmembrane protein that after proteolytic ectodomain shedding can be detected in serum as processed Klotho (p-KL), and a shorter transcript which codes for a putatively secreted protein (s-KL). Both isoforms exhibit potent pleiotropic beneficial properties, although previous reports showed negative side effects on mineral homeostasis after increasing p-KL concentration exogenously. Here, we expressed independently both isoforms using gene transfer vectors, to assess s-KL effects on mineral metabolism. While mice treated with p-KL presented altered expression of several kidney ion channels, as well as altered levels of P and Ca 2+ in blood, s-KL treated mice had levels comparable to Null-treated control mice. Besides, bone gene expression of Fgf23 showed a fourfold increase after p-KL treatment, effects not observed with the s-KL isoform. Similarly, bone microstructure parameters of p-KL-treated mice were significantly worse than in control animals, while this was not observed for s-KL, which showed an unexpected increase in trabecular thickness and cortical mineral density. As a conclusion, s-KL (but not p-KL) is a safe therapeutic strategy to exploit KL anti-aging protective effects, presenting no apparent negative effects over mineral metabolism and bone microstructure.
KW - Biochemistry
KW - Drug discovery
KW - Genetics
KW - Medical research
KW - Molecular biology
KW - Molecular medicine
KW - Bone and Bones/metabolism
KW - Protein Isoforms/metabolism
KW - Minerals/metabolism
KW - Klotho Proteins/metabolism
KW - Kidney/metabolism
KW - Mice, Knockout
KW - Animals
KW - Glucuronidase/genetics
KW - Mice
UR - http://www.scopus.com/inward/record.url?scp=85150687296&partnerID=8YFLogxK
U2 - 10.1038/s41598-023-31117-6
DO - 10.1038/s41598-023-31117-6
M3 - Article
C2 - 36918615
SN - 2045-2322
VL - 13
JO - Scientific Reports
JF - Scientific Reports
M1 - 4211
ER -